Digital era of drug development
The Indian pharma sector needs more actionable and optimised drug development and delivery models driven by data and new-age…
Author
‘The biggest barrier to innovation of supply chain is businesses becoming too complacent with the…
Joseph Lim, Sales Director APAC, BluJay Solutions, speaks on how vital it is to transform pharma industry's supply chain systems…
‘The global drug development division is the engine that powers the Novartis pipeline’
The Global Drug Development (GDD) centre in Hyderabad, is one of the three major global development sites for Novartis.
Arno…
‘Clinical research services at most leading pharma and biotech companies contain at least one…
Karan Daftary, Director, Business Development and Akshay Daftary, Director, Business Development, Siro Clinpharm, speak on the…
About one-third of the revenues generated by drug companies is spent on transportation
Snowman Logistics, an integrated temperature-controlled logistics services provided has been increasing its pan-India presence…
The ingredient for success
As India’s only manufacturer and one of the top few global manufacturers of Vitamin D3, Fermenta Biotech has a very interesting…
Increasing number of biologics losing patents presents India with great opportunity
Shakthi M Nagappan, Director (Life Science and Pharma), Government of Telangana, speaks on the BIO Asia International Conference,…
DCGI delivers BV Patel Memorial Lecture at IPC 2018
Urges that building trust in India's medicines and positive image of regulators is the need of the hour
Industry stakeholders discuss on opportunities and challenges in biosimilars at IPC 2018
Hope that in the coming years India will contribute significantly to the growth of the biosimilars sector globally
Trends in medical devices in changing regulatory environment discussed at IPC 2018
The session addresses aspects such as data security, affordability of medical devices, impact on healthcare outcomes and…